Splittable tablets for supporting the locomotor system in dogs and cats Aplazyl
Properties:
– is a complementary food that supports locomotor function and maintains healthy joints;
– lubricates joints, supports and preserves cartilage, completes the nutritional requirements of the locomotor system during growth and periods of intense effort and maintains joint flexibility;
– contains much more than glucosamine and chondroitin. The other components of 100% natural origin protect and support the formation of cartilage and synovial fluid.
Action:
It is used in old animals, also in growing animals, during convalescence and restoration, in sports animals during the preparation and recovery period, in pregnant and / lactating females.
Target species:
Dogs and cats.
How to use:
Oral administration, in food or directly into the mouth.
Growing puppies: 1/2 – 1 tablet / day, starting from 6 weeks to 6 months of age.
Dogs in recovery, convalescent, sports dogs, dogs showing signs of stiffness:
1 tablet / day /10 kg for 1-2 months.
Older dogs, pregnant / lactating bitches:
< 20 kg: 1 tablet / day.
> 20 kg: 2 tablets / day.
Older cats, convalescent and with signs of stiffness: 1/2 tablet / day / 5 kg of body weight.
It is recommended to do a 12-week cure, 2 times a year for the maintenance of older animals, for pregnant animals 30 days before and 60 days after calving.
Composition:
Green-lipped mussel powder (Perna canaliculus), glucosamine sulfate, chondroitin sulfate, green algae powder (Chlorella pyrenoidosa), fish oil, stinging nettle powder (Urtica urens).
Analytical constituents:
Crude protein 37.8%, crude ash 14.0%, crude fat 10.0%, crude cellulose 0.5%.
Additives:
Trace elements: manganese chelated with amino acids, hydrated, Mn (E5) 2400 mg/kg. Aromatic substances-plant extracts: devil’s claw extract (Harpagofitum procumbens) 16,000 mg/kg, Boswellia resin extract (Boswellia serrata) 60,000 mg/kg,
Storage:
Store at room temperature, in the original packaging.
Keep out of reach of children.
Reviews
There are no reviews yet.